Humatrope® [somatropin (rDNA origin) for injection] is a treatment made by Eli Lilly and Company. Eli

Lilly is a globe spanning research and pharmaceutical firm with it’s headquarters in Indianapolis, Indiana.

The firm did more than $24 billion in revenue in 2012 and spends $5 billion dollars a year in research

alone.

Humatrope® is considered the “Gold Standard” by many industry professionals. The overall longevity

benefits of Humatrope® can be seen and felt within the first months of treatment. This product is aimed

for long term treatments to achieve the best results. Mostly used for general longevity purposes.